# Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study

> **NCT01239888** · PHASE1 · UNKNOWN · sponsor: **The Alfred** · enrollment: 15 (estimated)

## Conditions studied

- Depression
- Major Depressive Disorder

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Oxytocin and Tibolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01239888
- **Lead sponsor:** The Alfred
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2012-11
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2012-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239888, "Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01239888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
